Life Sciences After Hours
Join us for an engaging, interactive discussion on the lessons the life sciences industry is learning from FDA Complete Response Letters (CRLs).
Hear different perspectives, share experiences, and explore practical ways to avoid common regulatory pitfalls and build stronger submissions.
Continue the conversation over drinks and light refreshments while networking with Basel life science professionals and our team.
Speakers:
-
Andrea Bertaglia – Head of Drug Substance Analytical Operations, Ironwood Pharma
- Karoline Hahn, PhD - Head of Regulatory Affairs, Luminance Health
-
Daniel Galbraith, PhD - Chief Scientific Officer, Solvias
October 20, 2026 | 5:00 – 8:30 PM CEST
MC3 Main Campus Convention Center ( Room 4 )
Hegenheimermattweg 167D, 4123 Allschwil, Switzerland
Doors are open from 5:00 PM to 8:30 PM. Stop in when it works best for you.
RSVP now.
What’s Happening
Come for a quick hello or stay for the full experience, it’s completely up to you.
5:00 – 5:30 PM
Arrivals & Networking
5:30 – 6:15 PM
Panel Discussion
Dear Sponsor, We Regret to Inform You: Avoiding FDA's Most Common CRLs
6:15 – 8:30 PM
Networking Apéro
